Consalvo, said Schering-Plough has listened to the concerns of patient advocates and is developing a program to help provide ribavirin to hepatitis patients whose doctors can prove that the patients have a need for it.
According to this week's New England Journal of Medicine, six months after treatment, patients who received the two-drug combination were more likely to be free of hepatitis C than they would be if they accepted the traditional drug treatment of interferon.
Some doctors and patient groups have criticized Schering-Plough for refusing to "unbundle" the two drugs, marketed as a product called Rebetron, so that patients could use Ribavirin with another brand of interferon.
The Food and Drug Administration on Wednesday approved a powerful combination of two antiviral drugs to treat chronic hepatitis C, a liver infection that can lead to cirrhosis, liver cancer and liver failure.
Fisher's Specialized Pharmacy Services in Pittsburgh has announced plans to fill prescriptions nationwide for the anti-viral drug ribavirin, used by growing numbers of hepatitis C patients in combination with the drug interferon.
Only one-third of patients who gave themselves weekly thigh injections of the drug developed MS within three years, compared with half the patients who injected a harmless substance.
"That was exciting, because now we had a treatment that could potentially help her" without having the drastic side effects of radiation therapy, Kaban said Monday. Folkman reasoned, "You could give interferon alpha at a low dose every day" without causing the side effects it can trigger in large
